Moreover, most Vector-cell-injected mice had marked weight loss by 15 days post transplantation, whereas DNAJC10-OE-cell-injected mice had no obvious weight loss, to some extent indicating DNAJC10 overexpression inhibits GBM progression in vivo (Fig. S5). The gene discussed is DNAJC10; the disease is glioblastoma.